Shukra Pharmaceuticals Declares Unaudited Q2 FY27 Results

Shukra Pharmaceuticals Ltd announced its unaudited financial results for the quarter and half-year ended September 30, 2026. The Board of Directors approved these results, along with the limited review reports from the statutory auditors. The company also reviewed other business matters. The results are available on the company's website and BSE India. The company operates in two segments: Shukra Pharmaceutical and Shukra MedTech. During the half-year, convertible warrants were converted into equity shares, increasing the share capital. The company's name changed from Shukra Pharmaceuticals Limited to Shukra Medtech Limited effective October 12, 2026.